Psychedelic therapy – refining the claim of a paradigm shift.
Saved in:
| Title: | Psychedelic therapy – refining the claim of a paradigm shift. |
|---|---|
| Authors: | Aicher, Helena D., Wolff, Max, Herwig, Uwe |
| Source: | International Review of Psychiatry. Dec2024, Vol. 36 Issue 8, p920-927. 8p. |
| Subjects: | Mental illness drug therapy, Psychotherapy, Conceptual models, Hallucinogenic drugs, Paradigms (Social sciences), Psychology, Drug efficacy, Conceptual structures |
| Abstract: | The renewed interest in psychedelics as treatments for mental health disorders is often referred to as the "Psychedelic Renaissance." This article assesses whether this resurgence truly constitutes a paradigm shift in psychiatry, as some proponents claim, or if it should be viewed as an integration of existing therapeutic approaches. We explore historical contexts, noting that psychedelics were extensively researched in the mid-20th century and argue that many of the current claims about their novelty overlook prior knowledge and research from that period. While psychedelics do introduce novel aspects, such as rapid therapeutic effects and unique modes of action, we challenge the idea of a full paradigm shift, suggesting that these developments are better understood as enhancements to existing frameworks rather than a wholesale replacement. We emphasize the importance of integrating psychedelics within a broader bio-psycho-social model of psychiatry, combining pharmacological, psychological, and contextual factors. The therapeutic potential of psychedelics in psychotherapy has previously been described as working as "nonspecific amplifiers" of psychological processes, rather than introducing entirely new mechanisms. We suggest a balanced, integrative approach that incorporates psychedelics into existing mental health care models, cautioning against "psychedelic exceptionalism" and the risk of overselling their potential as a revolutionary treatment. [ABSTRACT FROM AUTHOR] |
| Copyright of International Review of Psychiatry is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 183195384 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Psychedelic therapy – refining the claim of a paradigm shift. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Aicher%2C+Helena+D%2E%22">Aicher, Helena D.</searchLink><br /><searchLink fieldCode="AR" term="%22Wolff%2C+Max%22">Wolff, Max</searchLink><br /><searchLink fieldCode="AR" term="%22Herwig%2C+Uwe%22">Herwig, Uwe</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22International+Review+of+Psychiatry%22">International Review of Psychiatry</searchLink>. Dec2024, Vol. 36 Issue 8, p920-927. 8p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Mental+illness+drug+therapy%22">Mental illness drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Psychotherapy%22">Psychotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Conceptual+models%22">Conceptual models</searchLink><br /><searchLink fieldCode="DE" term="%22Hallucinogenic+drugs%22">Hallucinogenic drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Paradigms+%28Social+sciences%29%22">Paradigms (Social sciences)</searchLink><br /><searchLink fieldCode="DE" term="%22Psychology%22">Psychology</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+efficacy%22">Drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22Conceptual+structures%22">Conceptual structures</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The renewed interest in psychedelics as treatments for mental health disorders is often referred to as the "Psychedelic Renaissance." This article assesses whether this resurgence truly constitutes a paradigm shift in psychiatry, as some proponents claim, or if it should be viewed as an integration of existing therapeutic approaches. We explore historical contexts, noting that psychedelics were extensively researched in the mid-20th century and argue that many of the current claims about their novelty overlook prior knowledge and research from that period. While psychedelics do introduce novel aspects, such as rapid therapeutic effects and unique modes of action, we challenge the idea of a full paradigm shift, suggesting that these developments are better understood as enhancements to existing frameworks rather than a wholesale replacement. We emphasize the importance of integrating psychedelics within a broader bio-psycho-social model of psychiatry, combining pharmacological, psychological, and contextual factors. The therapeutic potential of psychedelics in psychotherapy has previously been described as working as "nonspecific amplifiers" of psychological processes, rather than introducing entirely new mechanisms. We suggest a balanced, integrative approach that incorporates psychedelics into existing mental health care models, cautioning against "psychedelic exceptionalism" and the risk of overselling their potential as a revolutionary treatment. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of International Review of Psychiatry is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=183195384 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/09540261.2024.2410853 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 920 Subjects: – SubjectFull: Mental illness drug therapy Type: general – SubjectFull: Psychotherapy Type: general – SubjectFull: Conceptual models Type: general – SubjectFull: Hallucinogenic drugs Type: general – SubjectFull: Paradigms (Social sciences) Type: general – SubjectFull: Psychology Type: general – SubjectFull: Drug efficacy Type: general – SubjectFull: Conceptual structures Type: general Titles: – TitleFull: Psychedelic therapy – refining the claim of a paradigm shift. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aicher, Helena D. – PersonEntity: Name: NameFull: Wolff, Max – PersonEntity: Name: NameFull: Herwig, Uwe IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09540261 Numbering: – Type: volume Value: 36 – Type: issue Value: 8 Titles: – TitleFull: International Review of Psychiatry Type: main |
| ResultId | 1 |
